SANTA CRUZ – The U.S. Drug Enforcement Administration (DEA) has formally approved the first-ever randomized controlled trial of whole plant medical marijuana (cannabis) as a treatment for posttraumatic stress disorder (PTSD) in U.S. veterans. The DEA’s approval marks the first time a clinical trial intended to develop smoked botanical marijuana
DEA Approves First-Ever Trial Of Medical Marijuana For PTSD In Vets
Non-profit MAPS receives $2.156 million grant from State of Colorado for first clinical trial of whole plant marijuana for PTSD treatment,
